ArticleBMC microbiology2026
Mycobacterium leprae small heat shock protein-18 complements Lon protease in Escherichia coli.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In Mycobacterium leprae (M. leprae), the small heat shock protein Hsp18 has been reported to function as a chaperone in vitro. The stability and activity of Hsp18 protein was increased by stress induced post-translational modification. The significant identity and similarity with a conserved sequence GVDP and proteolytic active site between M. leprae Hsp18 and E. coli and M. smegmatis Lon proteases reveals that, Hsp18 will have additional role in vivo that remains unexplored. In this study, we characterized the protease activity of M. leprae Hsp18 by complementing the Lon protease of Escherichia coli (E. coli). The MG1655Δlon mutant of E. coli, which lack the Lon protease overexpress capsular polysaccharide and form mucoid colonies. Similarly, E. coli SG20780 is the cpsB10::lac fusion that is lac+ and expresses lacZ, and both the strains are sensitive to methyl methane sulphonate (MMS) induced DNA damage. Upon induced expression of M. leprae Hsp18 in MG1655Δlon strain the mucoid phenotype was reversed by downregulating rcsA and in SG20780 mutant, lacZ expression was inhibited. In these E. coli mutants M. leprae Hsp18 expression conferred resistance to MMS in a concentration-dependent manner. In patients with leprosy, the polymorphic variants Hsp18S and Hsp18P have been identified, where the codon 52 encodes serine and proline respectively. Among these variants, Hsp18S showed higher protease activity and MMS resistance than the Hsp18P variant. Induced expression of N- and C-terminal domains of M. leprae Hsp18 in MG1655Δlon and SG20780, restored the Δlon phenotype suggesting that both the terminals act in synergy for the proteolytic activity. Thus, our study demonstrates that M. leprae Hsp18 is a protease which has similar function as that of Lon protease in E. coli. The chaperone activity and the proteolytic activity of Hsp18 is pivotal for the survival of M. leprae in vivo within the macrophages as chaperone by refolding the misfolded proteins and proteolytic cleavage of misfolded and damaged proteins during pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.